|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 262, Issue 5 E651-E657, Copyright © 1992 by American Physiological Society
ARTICLES |
K. Kohara, K. B. Brosnihan, C. M. Ferrario and A. Milsted
Department of Brain and Vascular Research, Cleveland Clinic Foundation, Ohio 44195.
We investigated whether angiotensin (ANG) II has the potential to regulate expression of genes of the renin-angiotensin system (RAS) in peripheral and central tissues. ANG II (0.1 or 6.0 nmol/h) was infused by osmotic minipump into male Sprague-Dawley rats (225-250 g) for 5 days, either intravenously or intracerebroventricularly. We measured angiotensinogen mRNA in liver, adrenal glands, and brain (hypothalamus and lower brain stem), renin mRNA in the kidney, and angiotensin-converting enzyme (ACE) mRNA in the lung and testis by Northern blot analysis. We demonstrated that plasma ANG II increases the levels of liver angiotensinogen mRNA, decreases kidney renin mRNA, and decreases lung ACE mRNA. Intracerebroventricular administration of ANG II resulted in a different pattern of responses of the peripheral RAS components. Liver angiotensinogen mRNA was increased, and kidney renin mRNA was decreased by both doses of ANG II, whereas lung ACE mRNA remained unresponsive at either dose. Centrally mediated influences of ANG II are most likely indirect since plasma ANG II concentration was not changed. This study has revealed that ANG II has profound diverse effects that influence the regulation of its formation. Further, results indicate that genes of the RAS responded to exogenous ANG II in both tissue- and route-specific ways.
This article has been cited by other articles:
![]() |
M. Nishimura, K. Ohtsuka, N. Iwai, H. Takahashi, and M. Yoshimura Regulation of brain renin-angiotensin system by benzamil-blockable sodium channels Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1416 - R1424. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tamura, N. Nyui, N. Tamura, T. Fujita, M. Kihara, Y. Toya, I. Takasaki, N. Takagi, M. Ishii, K.-i. Oda, et al. Mechanism of Angiotensin II-mediated Regulation of Fibronectin Gene in Rat Vascular Smooth Muscle Cells J. Biol. Chem., October 9, 1998; 273(41): 26487 - 26496. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tamura, S. Umemura, Y. Sumida, N. Nyui, S.-i. Kobayashi, T. Ishigami, M. Kihara, T. Sugaya, A. Fukamizu, H. Miyazaki, et al. Effect of Genetic Deficiency of Angiotensinogen on the Renin-Angiotensin System Hypertension, August 1, 1998; 32(2): 223 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Costerousse, J. Allegrini, J.-P. Clozel, J. Ménard, and F. Alhenc-Gelas Angiotensin I-Converting Enzyme Inhibition but Not Angiotensin II Suppression Alters Angiotensin I-Converting Enzyme Gene Expression in Vessels and Epithelia J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1180 - 1187. [Abstract] [Full Text] |
||||
![]() |
M. J. Rieder, R. J. Roman, and A. S. Greene Reversal of Microvascular Rarefaction and Reduced Renal Mass Hypertension Hypertension, July 1, 1997; 30(1): 120 - 127. [Abstract] [Full Text] |
||||
![]() |
A. Milsted, M. Nishimura, K. B. Brosnihan, and C. M. Ferrario Differential Regulation of Angiotensinogen Transcripts After Renin Infusion Hypertension, October 1, 1996; 28(4): 678 - 681. [Abstract] [Full Text] |
||||
![]() |
A. R. Brasier and J. Li Mechanisms for Inducible Control of Angiotensinogen Gene Transcription Hypertension, March 1, 1996; 27(3): 465 - 475. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |